IGHD5OR15-5B

Across TCGA pan-cancer cohorts, IGHD5OR15-5B RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated IGHD5OR15-5B data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher IGHD5OR15-5B RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated IGHD5OR15-5B expression acts as an unfavorable survival marker.

STAD are the cancer types where IGHD5OR15-5B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.149	0.710	<.001	63	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

IGHD5OR15-5B–STAD (DFS)

Open the STAD breakdown →